To evaluate the sensitivity of the assay, a serial dilution of lung cancer cell lines carrying EGFR mutations (Ma1 or 11–18) into wild-type cell lines (A549) was analyzed by ultrarapid PCR using the mutation-specific primers. The gene discussed is EGFR; the disease is lung carcinoma.